Portrait of board member Clay Alspach

Clay Alspach, JD

Principal, Leavitt Partners

Clay Alspach is a principal based in Washington, D.C. Clay specializes in federal health care policy and advocacy related to the FDA, Medicare, Medicaid, private health insurance, digital health, public health, and pandemic preparedness.

Prior to joining Leavitt Partners, Clay served as Chief Health Counsel for Chairman Fred Upton of the U.S. House of Representatives Energy and Commerce Committee. During seven years with the committee, Clay spearheaded legislative initiatives that successfully reformed the SGR (MACRA), reauthorized FDA user fees (FDASIA), established a national system for drug supply chain security (Drug Quality and Security Act), strengthened the nation’s preparedness for chemical, biological, radiological, and nuclear threats, natural disasters, and emerging infectious diseases (Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA)), and advanced medical research and fostered a new era of medical innovations (21st Century Cures Act).

Prior to this service for the committee, Clay clerked for the Honorable Ronald L. Buckwalter of the U.S. District Court for the Eastern District of Pennsylvania and worked as a litigator in private law practice. He also worked as a legislative clerk at the committee from 1999 to 2000 under Chairman Thomas J. Bliley (R-VA). Clay received his bachelors of arts cum laude from the University of Richmond and holds a juris doctor from the University of Texas at Austin.